<DOC>
	<DOCNO>NCT01019070</DOCNO>
	<brief_summary>The purpose study assess effect hepatic impairment multiple dose pharmacokinetics BMS-650032 .</brief_summary>
	<brief_title>Hepatic Impaired Subjects Compared Healthy Subjects Receiving Multi-dose BMS-650032</brief_title>
	<detailed_description />
	<mesh_term>Hepatic Insufficiency</mesh_term>
	<criteria>Male female subject age 18 70 , hepatic impairment conform ChildPugh class A , B C Each match control subject determine healthy History esophageal gastric bleed within past 6 month Primarily cholestatic liver disease Active alcoholic hepatitis Stable encephalopathy â‰¥Stage 2 Presence severe ascites edema Presence hepatopulmonary hepatorenal syndrome Positive HIV Positive HCV , unless HCV RNA undetectable</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>